NCT04869371 2022-12-29
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
Clinical Trials
1 trialsNeoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel × Triptorelin Pamoate × Genitourinary × Clear all